Bioconnection Bv — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

BioConnection is a Netherlands-based, specialized CMO focused exclusively on aseptic fill & finish and lyophilization services for sterile injectable drug products. Operating from EMA and US-FDA approved facilities with three filling lines, it offers flexible, small to medium-scale production for both clinical trials and commercial supply. The company positions itself as a flexible, European partner providing tailored solutions, with additional capabilities in formulation and analytical development to accelerate client projects from tech transfer to market.

DiagnosticsAntibodies

Technology Platform

Specialized aseptic fill & finish and lyophilization (freeze-drying) services for sterile injectable drug products. Capabilities include multiple EMA/FDA-approved filling lines for vials and syringes, formulation development, analytical services, and tech transfer support.

Opportunities

Growing demand for outsourced sterile manufacturing, particularly for complex injectables and lyophilized products, from the expanding biopharma sector.

Strategic location in the Netherlands provides a high-quality, EU-based manufacturing hub for global clients.

Niche focus on flexible, small-to-medium batch sizes serves an underserved segment of the market.

Risk Factors

Regulatory risk associated with maintaining EMA and FDA compliance in sterile manufacturing.

High competition in the CDMO space from larger players with broader capabilities.

Dependence on the clinical and commercial success of client drug programs, which are subject to pipeline attrition and biotech funding cycles.

Competitive Landscape

BioConnection competes in the global Contract Development and Manufacturing Organization (CDMO) market, specifically within the sterile fill & finish segment. Competitors range from large, full-service CDMOs (e.g., Lonza, Catalent) to smaller, specialized players. Its differentiation is based on European location, regulatory approvals, lyophilization expertise, and a focus on personalized service and flexibility for clinical and small commercial batches.

More companies in Drug Delivery & Formulation →More companies in Netherlands →